CD38 and neoplasm: Extensive data has demonstrated the cooperation of CD38 with TCR signaling on T cells [37,38,39]; thus, the expression of CD38 and its activity in TCR signaling or cytotoxic functioning on tumor-infiltrating T cells needs to be more adequately investigated to determine whether disrupting CD38 via pharmacological inhibition would also impact T cell activation and cytotoxicity.